KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Current Deferred Revenue (2018 - 2026)

Fulgent Genetics' Current Deferred Revenue history spans 9 years, with the latest figure at $3.0 million for Q1 2026.

  • On a quarterly basis, Current Deferred Revenue rose 6.74% to $3.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $3.0 million, a 6.74% increase, with the full-year FY2025 number at $3.6 million, up 62.71% from a year prior.
  • Current Deferred Revenue hit $3.0 million in Q1 2026 for Fulgent Genetics, down from $3.6 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for FLGT hit a ceiling of $14.1 million in Q1 2022 and a floor of $2.2 million in Q4 2024.
  • Historically, Current Deferred Revenue has averaged $3.9 million across 5 years, with a median of $2.8 million in 2024.
  • Biggest five-year swings in Current Deferred Revenue: plummeted 80.62% in 2023 and later skyrocketed 62.71% in 2025.
  • Tracing FLGT's Current Deferred Revenue over 5 years: stood at $3.2 million in 2022, then decreased by 10.16% to $2.9 million in 2023, then dropped by 22.27% to $2.2 million in 2024, then skyrocketed by 62.71% to $3.6 million in 2025, then fell by 17.28% to $3.0 million in 2026.
  • Business Quant data shows Current Deferred Revenue for FLGT at $3.0 million in Q1 2026, $3.6 million in Q4 2025, and $2.3 million in Q3 2025.